Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Proof has demonstrated consistent performance in the California market, particularly in the Tincture & Sublingual category, where it has maintained a steady 8th place ranking from December 2025 through March 2026. This stability suggests a strong foothold in this category. However, in the Topical category, Proof's ranking slipped from 9th in January 2026 to 12th by March 2026, indicating a potential area for improvement. Notably, Proof did not appear in the top 30 brands for the Concentrates category until March 2026, when it achieved a rank of 96, which could be seen as an opportunity for growth or a challenge in penetrating this segment.
In the Capsules category, Proof held its position around the 10th and 11th spots from December 2025 to March 2026, reflecting a stable presence but with room for upward movement. The sales figures for this category saw a slight dip in February 2026 but rebounded in March, suggesting resilience. The absence of Proof in the top 30 rankings for several months in the Concentrates category highlights a potential gap in market presence there. Overall, the brand's performance across categories in California reflects both consistency in certain areas and opportunities for growth in others.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in California, Proof consistently maintained its 8th rank from December 2025 through March 2026. This stability in ranking suggests a steady performance amidst fluctuating sales figures. Notably, ABX / AbsoluteXtracts held a firm grip on the 6th position throughout the same period, indicating a stronger market presence. Meanwhile, Friendly Farms showed a slight improvement, moving from 9th to 7th rank, potentially posing a competitive threat to Proof. Mary's Medicinals experienced a dip in rank from 7th to 11th, which might have provided Proof with an opportunity to strengthen its market position. Despite these shifts, Proof's consistent ranking suggests a loyal customer base, though it may need to strategize to climb higher in the ranks and increase sales in the face of competitors like ABX / AbsoluteXtracts and Friendly Farms.

Notable Products
In March 2026, Proof's top-performing product was the CBD/THC 1:1 Bazillion Tincture Drops (1000mg CBD, 1000mg THC, 15ml), maintaining its number one rank for four consecutive months with sales of $760. The High THC Tincture (1000mg THC, 15ml) also held steady in the second position, showing an increase in sales from February to March. The CBD/THC 20:1 Tincture (300mg CBD, 15mg THC, 15ml) moved up to the third position, recovering from a previous absence in February. The CBD Rich Tincture Drops (1000mg CBD, 15ml) improved its ranking to fourth place, reflecting a slight sales increase. Lastly, the CBN/THC 1:1 Sleepy Tincture Drops (150mg CBN, 150mg THC, 15ml) re-entered the rankings at fifth, despite experiencing a decline in sales since December 2025.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







